A chimera is an organism that carries two or more distinct sets of DNA, each originating from a different fertilized egg. Unlike a simple genetic mutation, where a single error creates variation within one genetic blueprint, a chimera literally contains cells from what would have been two separate individuals. This happens more often than most people realize, with some estimates suggesting 5 to 15 percent of people may carry some form of chimerism.
How Chimerism Differs From Mosaicism
These two terms get confused constantly, but the distinction is straightforward. Mosaicism means one fertilized egg developed a mutation after conception, creating two slightly different cell lines within a single person. Chimerism means cells from two different fertilized eggs ended up in the same body. In mosaicism, there was always one individual. In chimerism, there were originally two.
How Someone Becomes a Chimera
The most dramatic form is called tetragametic chimerism. This happens when a woman releases two eggs, both get fertilized (which would normally produce fraternal twins), and the two embryos fuse very early in development. The result is a single person whose body is a patchwork of two genetically distinct cell populations. If the twin embryos were different sexes, the chimera may have a mix of XX and XY cells, though this doesn’t always cause visible differences. In a review of 50 individuals with both XX and XY cell lines, only about half had ambiguous or intersex physical traits. The rest appeared typically male or female.
This type of “whole body” chimerism is considered rare, though its true frequency is unknown because most chimeras have no idea they carry two sets of DNA. Some researchers have suggested the rate could be comparable to the rate of fraternal twinning, since the conditions that produce both are essentially the same.
Microchimerism: The Common Kind
The most widespread form of chimerism isn’t dramatic at all. During pregnancy, cells pass back and forth between mother and fetus through the placenta. This two-way exchange, called microchimerism, begins as early as four to six weeks of gestation and increases throughout pregnancy. By the third trimester, fetal DNA can make up roughly 2.7 percent of the total DNA circulating in the mother’s blood.
Most of these fetal cells get cleared by the mother’s immune system in the weeks after birth. But not all of them. Researchers have found fetal cells integrated into maternal tissues up to 27 years after delivery using Y chromosome detection (looking for male DNA in mothers who had sons). In one case, cells persisted in a woman’s thyroid for 38 years after she gave birth. The traffic goes both ways, too. Maternal cells cross into the fetus and can remain in the child’s body long after birth.
This means that most women who have been pregnant are, technically, chimeras. They carry a small number of cells with their child’s DNA scattered through their organs. And most people who were carried in a womb have a few of their mother’s cells living quietly inside them.
Medical Procedures That Create Chimeras
A bone marrow transplant (more precisely, a hematopoietic cell transplant) creates a chimera by design. Once donor stem cells engraft and begin producing blood cells, the recipient’s blood carries the donor’s DNA while the rest of their body retains their original genetic identity. This isn’t temporary. Production of donor cells from the engrafted bone marrow is an ongoing process, making the recipient a true biological chimera for as long as the transplant functions.
Doctors actually monitor this deliberately. After a transplant, they run chimerism tests to measure what proportion of a patient’s blood cells carry donor DNA versus recipient DNA. Complete chimerism, where all detectable blood cells are donor-derived, signals a successful transplant. Mixed chimerism, where both donor and recipient cells are present, can sometimes indicate the original disease is returning.
When Chimerism Causes Real Problems
Lydia Fairchild’s case is the most famous example of chimerism colliding with the legal system. In 2002, Fairchild applied for government assistance in Washington state and was required to prove she was her children’s mother through DNA testing. The test said she wasn’t. The state accused her of fraud and filed a lawsuit.
Three separate cheek swab tests all came back the same: no genetic match between Fairchild and her children, despite a clear match with their father. Photographs, the father’s testimony that he’d witnessed both births, even hospital footprint records from the deliveries were all dismissed. At the time, US courts treated DNA evidence as essentially infallible.
The case turned when Fairchild’s lawyer discovered a 2002 paper in The New England Journal of Medicine about Karen Keegan, a woman who needed a kidney transplant. When her family was tested for compatibility, doctors found she wasn’t the genetic mother of two of her three children. Researchers eventually identified her as a tetragametic chimera. The DNA in her blood was different from the DNA in other tissues, and her children had inherited the “other” set.
Armed with this precedent, Fairchild’s legal team took a DNA sample from her cervix instead of her cheek. There, they found a second DNA lineage that matched her children. Her mother’s DNA confirmed the family connection, and the judge dismissed the case. Fairchild had been a chimera her entire life without knowing it. The cells lining her cheek carried one genome while her reproductive organs carried another.
Effects on DNA Testing
Fairchild’s case exposed a blind spot in forensic science. Standard DNA tests sample cells from one location, usually the inside of the cheek or a blood draw, and assume those results represent the entire body. For a chimera, that assumption is wrong. A cheek swab and a blood sample could yield completely different genetic profiles from the same person.
This has implications beyond paternity disputes. In the Keegan case, the DNA in her blood was genetically distinct from what her children inherited. She was, in genetic terms, her children’s aunt rather than their mother, because her blood DNA came from the twin embryo that had fused with her before birth. Commercial ancestry tests, forensic crime scene analysis, and organ donor matching all rely on the assumption that your DNA is the same throughout your body. For chimeras, it isn’t.
Physical Signs of Chimerism
Most chimeras have no visible signs at all. When physical differences do appear, they can include patches of skin with slightly different pigmentation, two different eye colors (heterochromia), or skin patterns that follow lines of embryonic cell migration. In sex-discordant chimeras, where the two original embryos were male and female, there can be differences in reproductive anatomy, but even this is far from guaranteed. Many sex-discordant chimeras develop entirely typical male or female bodies.
The invisibility of chimerism is exactly what makes it so hard to study. Without a reason to run multiple DNA tests on different body tissues, there’s no way to detect it. The cases that do get identified almost always surface by accident, through a failed DNA test, an unexpected transplant mismatch, or a medical workup for an unrelated condition.
Interspecies Chimera Research
Scientists are also working with chimeras that cross species boundaries. The goal is to grow human organs inside host animals for transplantation, potentially solving the organ shortage crisis. In 2019, Japan became one of the first countries to relax restrictions on this kind of research, allowing scientists to study animal embryos containing human cells.
International guidelines from the International Society for Stem Cell Research recommend that this research proceed incrementally, with researchers stopping at defined time points to assess how far chimerism has spread before continuing. The guidelines also encourage targeted approaches that limit human cells to a specific organ system rather than allowing them to integrate throughout the animal’s body.